The April through June period is proving so kind to equities that nearly 260 U.S.-listed ETFs — approximately 10% of the entire domestic exchange traded products universe — are higher by more than 30% this quarter.BBC's strategy is interesting as it “passively invests solely in firms with promising drugs in clinical human trials that have not yet been approved by the FDA or gone into production,” according to the issuer.